Caltag Medsystems Ltd. Erika B Ammirati 575 Shirlynn Court Los Altos, CA 94022

Re: K162723 Trade/Device Name: TransFix $^ \mathrm { \textregistered }$ /EDTA Vacuum Blood Collection Tubes Regulation Number: 21 CFR 862.1675 Regulation Name: Blood specimen collection device Regulatory Class: II Product Code: GIM Dated: May 24, 2017 Received: May 25, 2017

Dear Ms. Ammirati:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA’s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

Page 2—Dr. Sunmi Han

If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH’s Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

![](images/aa59309b72d25c69ab80342524ae6043d068ea6dee775190b3cc6a0c433c8a1c.jpg)

FOR   
Leonthena R. Carrington, MS, MBA, MT(ASCP)   
Director   
Division of Immunology and Hematology Devices   
Office of In Vitro Diagnostics and Radiological Health   
Center for Devices and Radiological Health

510(k) Number (if known) K162723

Device Name TransFix/EDTA Vacuum Blood Collection Tubes (TVTs)

Indications for Use (Describe)

TransFix/EDTBloo olub TVTtroln   who semens oohenotypn whit bloo l y ow ytomeryReoveryymhocyubset marker the HIV panel can be accomplished over a 14-day period following collection.

Prescription Use (Part 21 CFR 801 Subpart D)

# CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

Te burden tie or thi colectioniforation etiateoaveragehours per esponse,nclud tim  eviw instructions,searh existing dat sources atheran maintain he data needed and coplete an review the collection f information Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

# 510(k) SUMMARY

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. The assigned 510(k) number is K162723.

807.92 (a)(1): Name: Caltag Medsystems Ltd.

Address: Whiteleaf Business Centre 11, Little Balmer Buckingham MK18 1TF UK

Phone: 011 44 1280 827 460   
FAX: 011 44 1280 827 466

Contact: Mr. Daniel Harrison Quality Manager

807.92 (a)(2): Device name- trade name and common name, and classification

Trade name: TransFix $\textsuperscript { \textregistered }$ /EDTA Vacuum Blood Collection Tubes

Common Name: Blood specimen collection device- tubes, vacuum sample, with anticoagulant

Classification: 21 CFR $\ S$ 862.1675– blood specimen collection device   
Class: Class II   
Panel: Clinical Chemistry and Toxicology   
Product Code: GIM

807.92 (a)(3): Identification of the legally marketed predicate devices Cyto-Chex $\textsuperscript { \textregistered }$ BCT (Blood Collection Tubes, Streck Laboratories, Inc., Omaha, NE), cleared under K080552

# 807.92 (a)(4): Device Description

TransFix $\textsuperscript { \textregistered }$ /EDTA Vacuum Blood Collection Tubes (TVTs) are intended for collection and storage of human whole blood specimens for immunophenotyping of white blood cells (WBC, leukocytes) by flow cytometry up to 14-days following collection; the TVTs preserve the qualitative and quantitative leukocyte subset characteristics. Flow cytometry is used to identify subsets of leukocytes that can be distinguished on the basis of cell surface antigens using fluorescent antibodies.

The TransFix $\textsuperscript { \textregistered }$ /EDTA Vacuum Blood Collection Tubes (TVTs) consist of purple-capped polyethylene terephthalate blood collection tubes containing the paraformaldehyde based preservative, TransFix, and $\mathrm { K } _ { 3 } \mathrm { E D T A }$ at the correct volume to simultaneously stabilize and anticoagulate human whole blood at the time of collection. TVTs hold $3 \mathrm { m L }$ (final draw volume) with a tube dimension of $1 3 \mathrm { ~ x ~ } 7 5 \mathrm { m m }$ . TVTs are sterilized by gamma radiation. Further, the vacuum contained within the TVT ensures that the TransFix/EDTA reagent is administered at the correct ratio of 1 part TransFix/EDTA to 5 parts whole blood.

# 807.92 (a)(5): Intended Use

TransFix/EDTA Vacuum Blood Collection Tubes (TVTs) are intended for collection and storage of human whole blood specimens for immunophenotyping of white blood cells by flow cytometry. Recovery of lymphocyte subset markers of the HIV panel can be accomplished over a 14-day period following collection. TVTs are in-vitro diagnostic medical devices.

807.92 (a)(6): Technological Similarities and Differences to the Predicate The TransFix $\textsuperscript { \textregistered }$ /EDTA Vacuum Blood Collection Tubes are substantially equivalent to the CytoChex $\textsuperscript { \textregistered }$ BCT (BCT), Streck Laboratories, Inc., La Vista, NE), (K080552).   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>TransFix® / EDTA VacuumBlood Collection Tube</td><td rowspan=1 colspan=1>Cyto-Chex® BCT(K080552)</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>For the collection and storage ofblood specimens forimmunophenotyping of WBCby flow cytometry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Tube size</td><td rowspan=1 colspan=1>13 x 75mm</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Preservation of HIV markers</td><td rowspan=1 colspan=1>14 days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Tube type</td><td rowspan=1 colspan=1>Polyethylene terephthalate</td><td rowspan=1 colspan=1>Glass</td></tr><tr><td rowspan=1 colspan=1>Contents</td><td rowspan=1 colspan=1>Liquid reagent: K3EDTA andTransFix preservative</td><td rowspan=1 colspan=1>Liquid reagent: K3EDTA andpreservative</td></tr><tr><td rowspan=1 colspan=1>Sample volume</td><td rowspan=1 colspan=1>2.5mL</td><td rowspan=1 colspan=1>5 mL</td></tr><tr><td rowspan=1 colspan=1>Liquid reagent</td><td rowspan=1 colspan=1>0.5mL</td><td rowspan=1 colspan=1>75.8μ1</td></tr></table>

# 807.92 (b)(1,2): Brief Description of Nonclinical and Clinical Data

Reproducibility- Repro Studies 1 and 2 Repro Study 1:

The objective of the study (along with Reproducibility Study 2) was to assess the variability of the $3 \mathrm { m L }$ TransFix $^ { \mathrm { \textregistered } }$ /EDTA Vacuum Blood Collection Tube (TVT). This was achieved by collecting blood into six TVTs (two tubes from each of three lots) from five healthy subjects whose blood samples spanned the absolute cell count range for lymphocytes and their subsets. The study compared the lymphocyte absolute cell counts recorded from each TVT sample for three test time points (0, 12 and 15 days post venipuncture). At each time point, testing was performed with triplicate determinations on each of the duplicate TVTs from each of the three lots.

For each sample, all 6 biomarkers were tested (CD3, CD8, CD4, CD45, CD16/CD56, CD19). Thus, the components of variation for analysis included:

1. Between-Day   
2. Between- Tube Lot   
3. Between-Tube   
4. Between-Replicate   
5. Total precision (the combined precision of factors 1-4)

The data are presented in Tables 1-6.

<table><tr><td rowspan=1 colspan=1>′</td><td rowspan=1 colspan=1>CD3+</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-DaySD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-LotSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)% CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>′</td><td rowspan=1 colspan=3>Sample #   N  Mean</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>HC A</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>1470.3</td><td rowspan=1 colspan=1>49.2 (41.3-60.7)</td><td rowspan=1 colspan=1>3.3 (2.8-4.1)</td><td rowspan=1 colspan=1>52.2 (43.8-64.4)</td><td rowspan=1 colspan=1>3.5 (3.0-4.4)</td><td rowspan=1 colspan=1>46.0 (38.7-56.8)</td><td rowspan=1 colspan=1>3.1 (2.6-3.9)</td><td rowspan=1 colspan=1>14.6 (12.3-18.1)</td><td rowspan=1 colspan=1>1.0 (0.8-1.2)</td><td rowspan=1 colspan=2>89.9 (75.6-111.0) 6.1 (5.1-7.5)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>HC B</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>1183.6</td><td rowspan=1 colspan=1>46.0 (38.7-56.8)</td><td rowspan=1 colspan=1>3.9 (3.3-4.8)</td><td rowspan=1 colspan=1>41.4 (34.8-51.1)</td><td rowspan=1 colspan=1>3.5 (2.9-4.3)</td><td rowspan=1 colspan=1>28.5 (24.0-35.2)</td><td rowspan=1 colspan=1>2.4 (2.0-3.0)</td><td rowspan=1 colspan=1>16.4 (13.7-20.2)</td><td rowspan=1 colspan=1>1.4 (1.2-1.7)</td><td rowspan=1 colspan=1>72.8 (61.2-89.9)</td><td rowspan=1 colspan=1>6.2 (5.2-7.6)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>HC C</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>404.7</td><td rowspan=1 colspan=1>7.1 (6.0-8.8)</td><td rowspan=1 colspan=1>1.8 (1.52.2)</td><td rowspan=1 colspan=1>10.4 (8.7-12.8)</td><td rowspan=1 colspan=1>2.6 (2.2-3.2)</td><td rowspan=1 colspan=1>2.7 (2.3-3.4)</td><td rowspan=1 colspan=1>0.7 (0.6-0.8)</td><td rowspan=1 colspan=1>6.1 (5.1-7.5)</td><td rowspan=1 colspan=1>1.5 (1.3-1.9)</td><td rowspan=1 colspan=1>19.4 (16.3-23.9)</td><td rowspan=1 colspan=1>4.8(4.0-5.9)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>HC D</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>1334.9</td><td rowspan=1 colspan=1>5.9 (4.9-7.2)</td><td rowspan=1 colspan=1>0.4(0.40.5)</td><td rowspan=1 colspan=1>35.8 (30.1-4.3)</td><td rowspan=1 colspan=1>2.7 (2.3-3.3)</td><td rowspan=1 colspan=1>32.0 (26.99-39.5)</td><td rowspan=1 colspan=1>2.4 (2.0--3.0)</td><td rowspan=1 colspan=1>7.3(6.1-9.0)</td><td rowspan=1 colspan=1>0.5 (0.5-0.7)</td><td rowspan=1 colspan=1>62.4 (52.5-77.)</td><td rowspan=1 colspan=1>4.7(3.9-5.8)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>HC E</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>1458.9</td><td rowspan=1 colspan=1>25.7 (21.6-31.7)</td><td rowspan=1 colspan=1>1.8 (1.5-2.2)</td><td rowspan=1 colspan=1>62.9 (52.9-77.6)</td><td rowspan=1 colspan=1>4.3 (3.6-5.3)</td><td rowspan=1 colspan=1>22.0 (18.5-27.1)</td><td rowspan=1 colspan=1>1.5 (1.3-1.9)</td><td rowspan=1 colspan=1>16.4 (13.7-20.2)</td><td rowspan=1 colspan=1>1.1 (0.9-1.4)</td><td rowspan=1 colspan=1>82.5 (69.4-101.8)</td><td rowspan=1 colspan=1>5.7 (4.8-7.0)</td></tr></table>

Table 1 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD3 biomarker (individual and total $\% \mathrm { C V s }$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD8+</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-DaySD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-LotSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)% CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>Sample #</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>HC A</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>517.7</td><td rowspan=1 colspan=1>44.7 (37.5-55.1)</td><td rowspan=1 colspan=1>8.6 (7.2-10.6)</td><td rowspan=1 colspan=1>29.2 (24.6-36.1)</td><td rowspan=1 colspan=1>5.6 (4.7-7.0)</td><td rowspan=1 colspan=1>12.5 (10.5-15.5)</td><td rowspan=1 colspan=1>2.4 (2.0-3.0)</td><td rowspan=1 colspan=1>1.4 (1.1-1.7)</td><td rowspan=1 colspan=1>0.3 (0.2-0.3)</td><td rowspan=1 colspan=1>56.0 (47.1-69.1)</td><td rowspan=1 colspan=1>10.8 (9.1-13.4)</td></tr><tr><td rowspan=1 colspan=1>HC B</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>451.2</td><td rowspan=1 colspan=1>2.4 (21.3-31.3)</td><td rowspan=1 colspan=1>5.6 (4.7-6.9)</td><td rowspan=1 colspan=1>19.6 (16.5-24.3)</td><td rowspan=1 colspan=1>4.4 (3.7-5.4)</td><td rowspan=1 colspan=1>8.1 (6.8-10.0)</td><td rowspan=1 colspan=1>1.8(1.5-2.2)</td><td rowspan=1 colspan=1>5.2 (4.4-6.4)</td><td rowspan=1 colspan=1>1.1 (1.0-1.4)</td><td rowspan=1 colspan=1>34.1 (28.7-42.1)</td><td rowspan=1 colspan=1>7.6 (6.4-9.3)</td></tr><tr><td rowspan=1 colspan=1>HC C</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>167.7</td><td rowspan=1 colspan=1>8.6 (7.3-10.7)</td><td rowspan=1 colspan=1>5.2 (4.3-6.4)</td><td rowspan=1 colspan=1>11.3 (9.5-13.9)</td><td rowspan=1 colspan=1>6.7 (5.6-8.3)</td><td rowspan=1 colspan=1>3.6 (3.1-4.5)</td><td rowspan=1 colspan=1>2.2 (1.8-2.7)</td><td rowspan=1 colspan=1>3.1 (2.6-3.8)</td><td rowspan=1 colspan=1>1.8 (1.5-2..3)</td><td rowspan=1 colspan=1>16.6 (14.0-20.5)</td><td rowspan=1 colspan=1>9.9 (8.3-12.2)</td></tr><tr><td rowspan=1 colspan=1>HC D</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>758.4</td><td rowspan=1 colspan=1>11.2 (9.4-113.8)</td><td rowspan=1 colspan=1>1.5(1.2-1.8)</td><td rowspan=1 colspan=1>20.2 (17.0-24.9)</td><td rowspan=1 colspan=1>2.7(2.2-3.3)</td><td rowspan=1 colspan=1>7.4(6.2-9.1)</td><td rowspan=1 colspan=1>1.0 (0.8-1.2)</td><td rowspan=1 colspan=1>4.5 (3.8-5.6)</td><td rowspan=1 colspan=1>0.6(0.5-0.7)</td><td rowspan=1 colspan=1>46.8 (39.3-57.8)</td><td rowspan=1 colspan=1>6.2 (5.2-7.6)</td></tr><tr><td rowspan=1 colspan=1>HCE</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>572.1</td><td rowspan=1 colspan=1>3.4 (2.9-4.2)</td><td rowspan=1 colspan=1>0.6 (0.5-0.7)</td><td rowspan=1 colspan=1>27.1 (2.8-33.5)</td><td rowspan=1 colspan=1>4.7(4.0-5.9)</td><td rowspan=1 colspan=1>8.8 (7.4-10.9)</td><td rowspan=1 colspan=1>1.5 (1.3-1.9)</td><td rowspan=1 colspan=1>11.0 (9.22-13.6)</td><td rowspan=1 colspan=1>1.9 (1.6-2.4)</td><td rowspan=1 colspan=1>40.2 (33.8-49.6)</td><td rowspan=1 colspan=1>7.0 (5.9-8.7)</td></tr></table>

Table 2 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD8 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD4+</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-DaySD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-LotSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI) % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)% CV (95% CI)</td></tr><tr><td rowspan=1 colspan=2>Sample #   N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>HC A</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>767.5</td><td rowspan=1 colspan=1>29.9 (25.2-37.0)</td><td rowspan=1 colspan=1>3.9 (3.3-4.8)</td><td rowspan=1 colspan=1>29.5 (24.8-36.4)</td><td rowspan=1 colspan=1>3.8 (3.2-4.7)</td><td rowspan=1 colspan=1>21.6 (18.1-26.6)</td><td rowspan=1 colspan=1>2.8 (2.43.5)</td><td rowspan=1 colspan=1>12.5 (10.5-15.4)</td><td rowspan=1 colspan=1>1.6 (1.4-2.0)</td><td rowspan=1 colspan=1>59.0 (49.6-72.8)</td><td rowspan=1 colspan=1>7.7 (6.5-9.5)</td></tr><tr><td rowspan=1 colspan=1>HC B</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>685.0</td><td rowspan=1 colspan=1>25.4 (21.4-31.4)</td><td rowspan=1 colspan=1>3.7 (3.1-4.6)</td><td rowspan=1 colspan=1>7.9 (6.6-9.8)</td><td rowspan=1 colspan=1>1.2 (1.0-1.4)</td><td rowspan=1 colspan=1>11.6 (9.7-14.3)</td><td rowspan=1 colspan=1>1.7(1.4-2.1)</td><td rowspan=1 colspan=1>9.3 (7.9-11.5))</td><td rowspan=1 colspan=1>1.4 (1.1-1.7)</td><td rowspan=1 colspan=1>44.5 (37.4-54.9)</td><td rowspan=1 colspan=1>6.5 (5.5-8.0)</td></tr><tr><td rowspan=1 colspan=1>HC C</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>197.9</td><td rowspan=1 colspan=1>7.2 (6.1-8.9)</td><td rowspan=1 colspan=1>3.7 (3.1-4.5)</td><td rowspan=1 colspan=1>0.9 (0.8-1.1)</td><td rowspan=1 colspan=1>0.5 (0.4-0.6)</td><td rowspan=1 colspan=1>0.8 (0.7-1.0)</td><td rowspan=1 colspan=1>0.4 (0.3-0.5)</td><td rowspan=1 colspan=1>2.3 (1.9-2.8)</td><td rowspan=1 colspan=1>1.2(1.01.4)</td><td rowspan=1 colspan=1>16.0 (13.4-19.8)</td><td rowspan=1 colspan=1>8.1 (6.8-10.0)</td></tr><tr><td rowspan=1 colspan=1>HC D</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>496.3</td><td rowspan=1 colspan=1>11.9 (10.0-14.7)</td><td rowspan=1 colspan=1>2.4 (2.0-3.0)</td><td rowspan=1 colspan=1>11.4 (9.6-14.1)</td><td rowspan=1 colspan=1>2.3 (1.9-2.8)</td><td rowspan=1 colspan=1>8.0 (6.8-9.9)</td><td rowspan=1 colspan=1>1.6(1.4-2.0)</td><td rowspan=1 colspan=1>4.9 (4.1-6.1))</td><td rowspan=1 colspan=1>1.0 (0.8-1.2)</td><td rowspan=1 colspan=1>35.0 (29.4-43.2)</td><td rowspan=1 colspan=1>7.1 (5.9-8.7))</td></tr><tr><td rowspan=1 colspan=1>HC E</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>828.2</td><td rowspan=1 colspan=1>6.9 (5.8-8.5)</td><td rowspan=1 colspan=1>0.8 (0.7-1.0)</td><td rowspan=1 colspan=1>24.8 (20.9-30.6)</td><td rowspan=1 colspan=1>3.0 (2.5-3.7)</td><td rowspan=1 colspan=1>7.1 (5.9-8.7)</td><td rowspan=1 colspan=1>0.9 (0.7-1.1)</td><td rowspan=1 colspan=1>23.7 (19.9-29.2)</td><td rowspan=1 colspan=1>2.9 (2.4-3.5)</td><td rowspan=1 colspan=1>52.4(44.0-64.7)</td><td rowspan=1 colspan=1>6.3 (5.3-7.8)</td></tr></table>

able 3 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD4 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td colspan="3">Lymph CD45+</td><td colspan="2">Between-Day</td><td colspan="2">Between-Lot</td><td colspan="2">Between-Tube</td><td colspan="2">Between-Replicate</td><td colspan="2">Total</td></tr><tr><td>Sample #</td><td>N</td><td>Mean</td><td>SD (95% CI)</td><td>% CV (95% CI)</td><td>SD (95% CI)</td><td>% CV (95% CI)</td><td>SD (95% CI)</td><td>% CV (95% CI)</td><td>SD (95% CI)</td><td>% CV (95% CI)</td><td>SD (95% CI)</td><td>% CV (95% CI)</td></tr><tr><td>HC A</td><td>54</td><td>2306.7</td><td>70.3 (59.1-86.8)</td><td>3.0 (2.6-3.8)</td><td>67.7 (56.9-83.6)</td><td>2.9 (2.5-3.6)</td><td>7.0 (60.6-88.9)</td><td>3.1 (2.6-3.9)</td><td>18.3 (15.4-22.6)</td><td>0.8 (0.7-1.0)</td><td>127.1 (106.8-156.9]</td><td>5.5 (4.6-6.8)</td></tr><tr><td>HC B</td><td>54</td><td>1730.2</td><td>49.3 (41.4-60.9)</td><td>2.8(2.4-3.5)</td><td>63.5 (53.4-78.4)</td><td>3.7 (3.1-4.5)</td><td>29.7 (25.0-36.6)</td><td>1.7(1.4-2.1)</td><td>26.1 (21.9-32.2)</td><td>1.5 (1.3-1.9)</td><td>97.1 (81.6-119.9)</td><td>5.6 (4.7-6.9)</td></tr><tr><td>HC C</td><td>54</td><td>720.5</td><td>9.9 (8.3-12.2)</td><td>1.4 (1.2-1.7)</td><td>27.7 (23.2-34.1)</td><td>3.8 (3.2-4.7)</td><td>9.6 (8.1-11.9)</td><td>1.3 (1.1-1.6)</td><td>11.3 (9.5-14.0)</td><td>1.6(1.3-1.9)</td><td>37.5 (31.5-46.3)</td><td>5.2 (4.4-6.4)</td></tr><tr><td>HC D</td><td>54</td><td>1683.0</td><td>6.7 (5.6-8.2)</td><td>0.4(0.3-0.5)</td><td>34.2 (28.8-42.3)</td><td>2.0(1.77-2.5)</td><td>34.3 (28.842.3)</td><td>2.0 (1.77-2.5)</td><td>10.4(8.7-12.8))</td><td>0.6 (0.5-0.8)</td><td>75.8 (63.7-93.6)</td><td>4.5(3.8-5.6)</td></tr><tr><td>HCE</td><td>54</td><td>1952.0</td><td>19.3 (16.2-23.8)</td><td>1.0 (0.8-1.2)</td><td>88.5 (74.4-109.2)</td><td>4.5 (3.8-5.6)</td><td>34.4 (28.9-42.4)</td><td>1.8 (1.5-2.2)</td><td>20.2 (17.0-24.9)</td><td>1.0 (0.9-1.3)</td><td>107.8 (90.6-133.1)</td><td>5.5 (4.6-6.8)</td></tr></table>

Table 4 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD45 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=2>CD16+CD56+</td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-DaySD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-LotSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)% CV (95% CI)</td></tr><tr><td rowspan=1 colspan=3>Sample #   N  Mean</td></tr><tr><td rowspan=1 colspan=1>HC A</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>377.1</td><td rowspan=1 colspan=1>12.3 (10.4-15.2)</td><td rowspan=1 colspan=1>3.3 (2.8-4.0)</td><td rowspan=1 colspan=1>0.1 (0.1-0.1)</td><td rowspan=1 colspan=1>0.0 (0.0-0.0)</td><td rowspan=1 colspan=1>11.6 (9.7-14.3)</td><td rowspan=1 colspan=1>3.1 (2.6--3.8)</td><td rowspan=1 colspan=1>2.3 (2.00-2.9)</td><td rowspan=1 colspan=1>0.6 (0.5-0.8)</td><td rowspan=1 colspan=1>24.9 (20.9-30.7)</td><td rowspan=1 colspan=1>6.6 (5.6-8.2)</td></tr><tr><td rowspan=1 colspan=1>HC B</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>366.7</td><td rowspan=1 colspan=1>15.9 (13.4-1.9.6)</td><td rowspan=1 colspan=1>4.3 (3.6-5.4)</td><td rowspan=1 colspan=1>21.0 (17.7-26.0)</td><td rowspan=1 colspan=1>5.7(4.8-7.1)</td><td rowspan=1 colspan=1>4.3 (3.6-5.4)</td><td rowspan=1 colspan=1>1.2 (1.0-1.5)</td><td rowspan=1 colspan=1>8.0 (6.7-9.9)</td><td rowspan=1 colspan=1>2.2 (1.8-2.7)</td><td rowspan=1 colspan=1>31.1 (26.1-38.4)</td><td rowspan=1 colspan=1>8.5 (7.1-10.5)</td></tr><tr><td rowspan=1 colspan=1>HC C</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>209.5</td><td rowspan=1 colspan=1>6.4(5.4-7.9)</td><td rowspan=1 colspan=1>3.1 (2.66-3.8)</td><td rowspan=1 colspan=1>15.4 (13.0-19.0)</td><td rowspan=1 colspan=1>7.4(6.2-9.1)</td><td rowspan=1 colspan=1>5.2 (4.3-6.4)</td><td rowspan=1 colspan=1>2.5 (2.1-3.0)</td><td rowspan=1 colspan=1>3.4 (2.8-4.2)</td><td rowspan=1 colspan=1>1.6 (1.4-2.0)</td><td rowspan=1 colspan=1>17.2 (14.55-21.2)</td><td rowspan=1 colspan=1>8.2 (6.9-10.1)</td></tr><tr><td rowspan=1 colspan=1>HC D</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>217.7</td><td rowspan=1 colspan=1>6.4(5.4-7.9)</td><td rowspan=1 colspan=1>3.0 (2.5-3.6)</td><td rowspan=1 colspan=1>5.1(4.3-6.3)</td><td rowspan=1 colspan=1>2.3 (2.00-2.9)</td><td rowspan=1 colspan=1>4.2 (3.6-5.2)</td><td rowspan=1 colspan=1>1.9 (1.6-2.4))</td><td rowspan=1 colspan=1>3.9 (3.3-4.8)</td><td rowspan=1 colspan=1>1.8(1.5-2.2)</td><td rowspan=1 colspan=1>15.5(13.00-19.1)</td><td rowspan=1 colspan=1>7.1(6.0-8.8)</td></tr><tr><td rowspan=1 colspan=1>HCE</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>296.9</td><td rowspan=1 colspan=1>11.5 (9.7-14.2)</td><td rowspan=1 colspan=1>3.9 (3.3-4.8)</td><td rowspan=1 colspan=1>15.1 (12.7-18.7)</td><td rowspan=1 colspan=1>5.1 (4.3-6.3)</td><td rowspan=1 colspan=1>9.6 (8.1-11.8)</td><td rowspan=1 colspan=1>3.2 (2.7-4.0)</td><td rowspan=1 colspan=1>4.2 (3.5-5.2)</td><td rowspan=1 colspan=1>1.4 (1.2-1.8)</td><td rowspan=1 colspan=1>26.6 (22.4-32.8)</td><td rowspan=1 colspan=1>9.0 (7.5-11.11)</td></tr></table>

5 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD16/56 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively)

<table><tr><td rowspan=1 colspan=1>CD19+</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>Between-Day</td><td rowspan=2 colspan=2>Between-LotSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)% CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)% CV (95% CI)</td></tr><tr><td rowspan=1 colspan=3>Sample #   N  Mean</td><td rowspan=1 colspan=2>SD (95% CI)% CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>HC A</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>352.7</td><td rowspan=1 colspan=1>9.0 (7.66-11.2)</td><td rowspan=1 colspan=1>2.6 (2.22-3.2)</td><td rowspan=1 colspan=1>14.0(11.8-17.3)</td><td rowspan=1 colspan=1>4.0 (3.3-4.9)</td><td rowspan=1 colspan=1>4.7 (3.95.8)</td><td rowspan=1 colspan=1>1.3 (1.1-1.6)</td><td rowspan=1 colspan=1>6.5 (5.5-8.1)</td><td rowspan=1 colspan=1>1.9 (1.6-2.3)</td><td rowspan=1 colspan=1>26.2 (22.0-32.3)</td><td rowspan=1 colspan=1>7.4 (6.2-9.2)</td></tr><tr><td rowspan=1 colspan=1>HC B</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>112.9</td><td rowspan=1 colspan=1>2.0(1.6-2.4)</td><td rowspan=1 colspan=1>1.7 (1.5-2.1)</td><td rowspan=1 colspan=1>1.4 (1.11-1.7)</td><td rowspan=1 colspan=1>1.2 (1.1-1.5)</td><td rowspan=1 colspan=1>0.1 (0.11-0.2)</td><td rowspan=1 colspan=1>0.1 (0.1-0.1)</td><td rowspan=1 colspan=1>4.4 (3.7-5.4)</td><td rowspan=1 colspan=1>3.9 (3.3-4.8)</td><td rowspan=1 colspan=1>8.2 (6.9-10.1)</td><td rowspan=1 colspan=1>7.3 (6.1-9.0)</td></tr><tr><td rowspan=1 colspan=1>HC C</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>53.7</td><td rowspan=1 colspan=1>0.5 (0.40.6)</td><td rowspan=1 colspan=1>0.8 (0.7-1.0)</td><td rowspan=1 colspan=1>0.7 (0.6-0.9)</td><td rowspan=1 colspan=1>1.3 (1.1-1.6)</td><td rowspan=1 colspan=1>0.8(0.7-1.0)</td><td rowspan=1 colspan=1>1.5(1.2-1.8)</td><td rowspan=1 colspan=1>0.7 (0.6-0.9)</td><td rowspan=1 colspan=1>1.4(1.2-1.7)</td><td rowspan=1 colspan=1>4.4 (3.7-5.4)</td><td rowspan=1 colspan=1>8.2 (6.9--10.1)</td></tr><tr><td rowspan=1 colspan=1>HC D</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>106.5</td><td rowspan=1 colspan=1>1.6 (1.42.0)</td><td rowspan=1 colspan=1>1.5(1.3-1.9)</td><td rowspan=1 colspan=1>2.9 (2.43.5)</td><td rowspan=1 colspan=1>2.7 (2..3-3.3)</td><td rowspan=1 colspan=1>2.9 (2.5-3.6)</td><td rowspan=1 colspan=1>2.7 (2.3-3.4)</td><td rowspan=1 colspan=1>3.3 (2.7-4.0)</td><td rowspan=1 colspan=1>3.1 (2.6-3.8)</td><td rowspan=1 colspan=1>10.5 (88-13.0)</td><td rowspan=1 colspan=1>9.9 (8.33-12.2)</td></tr><tr><td rowspan=1 colspan=1>HCE</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>151.2</td><td rowspan=1 colspan=1>3.6 (3.0-4..4)</td><td rowspan=1 colspan=1>2.4 (2.0-2.9)</td><td rowspan=1 colspan=1>4.6 (3.8-5.6)</td><td rowspan=1 colspan=1>3.0 (2.5-3.7)</td><td rowspan=1 colspan=1>2.4 (2.0-2.9)</td><td rowspan=1 colspan=1>1.6 (1.3-2.0)</td><td rowspan=1 colspan=1>2.6(2.2-3.2)</td><td rowspan=1 colspan=1>1.7(1.4-2.1)</td><td rowspan=1 colspan=1>10.0 (8.4-12.3)</td><td rowspan=1 colspan=1>6.6 (5.6-8.2)</td></tr></table>

ble 6 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD19 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

Repro Study 2:

The objective of this study was to build on the data set provided in Reproducibility Study 1, and add the effect of site-to-site testing. This was achieved by collecting blood into six TVTs (from the same lot) from five healthy subjects whose blood samples spanned the absolute cell count range for lymphocytes and their subsets. The study compared the lymphocyte absolute cell counts recorded from each TVT sample after they were tested at three clinical flow cytometry laboratories in the UK in order to analyze the following components of variation:

1. Between-Site (TVT sample results from different clinical laboratories).   
2. Between-Tube (TVT sample results from a different tube, but of the same lot).   
3. Between-Replicate (TVT sample results from the same tube).   
4. Total precision (the combined precision of factors 1-3).

At each site, testing was performed with triplicate determinations on each of the duplicate TVTs using one lot of tubes. For each sample, all six biomarkers were tested (CD3, CD8, CD4, CD45, CD16/CD56, CD19). Thus, the components of variation for analysis included.

<table><tr><td rowspan=1 colspan=1>CD3</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-SiteSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)   % CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>Donor</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1441.1</td><td rowspan=1 colspan=1>85.5 (64.2-128.2)</td><td rowspan=1 colspan=1>5.9 (4.5-8.9)</td><td rowspan=1 colspan=1>17.4 (13.1-26.1)</td><td rowspan=1 colspan=1>1.2 (0.9-1.8)</td><td rowspan=1 colspan=1>24.2 (18.2-36.3)</td><td rowspan=1 colspan=1>1.7 (1.3-2.5)</td><td rowspan=1 colspan=1>97.0 (72.8-145.4)</td><td rowspan=1 colspan=1>6.7 (5.1-10.1)</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1435.7</td><td rowspan=1 colspan=1>107.4 (80.6-161.0)</td><td rowspan=1 colspan=1>7.5 (5.6-11.2)</td><td rowspan=1 colspan=1>13.2 (9.9-19.8)</td><td rowspan=1 colspan=1>0.9 (0.7-1.4)</td><td rowspan=1 colspan=1>28.7 (21.5-43.0)</td><td rowspan=1 colspan=1>2.0 (1.5-3.0)</td><td rowspan=1 colspan=1>103.9 (78.0-155.8)</td><td rowspan=1 colspan=1>7.2 (5.4-10.8)</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>372.3</td><td rowspan=1 colspan=1>12.4 (9.3-18.5)</td><td rowspan=1 colspan=1>3.3 (2.5-5.0)</td><td rowspan=1 colspan=1>9.5 (7.1-14.2)</td><td rowspan=1 colspan=1>2.5 (1.9-3.8)</td><td rowspan=1 colspan=1>20.7 (15.6-31.1)</td><td rowspan=1 colspan=1>5.6 (4.2-8.4)</td><td rowspan=1 colspan=1>28.4 (21.3-42.6)</td><td rowspan=1 colspan=1>7.6 (5.7-11.4)</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1416.6</td><td rowspan=1 colspan=1>90.1 (67.6-135.1)</td><td rowspan=1 colspan=1>6.4 (4.8-9.5)</td><td rowspan=1 colspan=1>46.8 (35.2-70.2)</td><td rowspan=1 colspan=1>3.3 (2.5-5.0)</td><td rowspan=1 colspan=1>78.3 (58.7-117.4)</td><td rowspan=1 colspan=1>5.5 (4.1-8.3)</td><td rowspan=1 colspan=1>122.2 (91.7-183.2)</td><td rowspan=1 colspan=1>8.6 (6.5-12.9)</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1195.1</td><td rowspan=1 colspan=1>52.0 (39.0-78.0)</td><td rowspan=1 colspan=1>4.4 (3.3-6.5)</td><td rowspan=1 colspan=1>49.9 (37.5-74.9)</td><td rowspan=1 colspan=1>4.2 (3.1-6.3)</td><td rowspan=1 colspan=1>67.1 (50.3-100.6)</td><td rowspan=1 colspan=1>5.6 (4.2-8.4)</td><td rowspan=1 colspan=1>86.0 (64.5-128.9)</td><td rowspan=1 colspan=1>7.2 (5.4-10.8)</td></tr></table>

demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD3 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD8</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-SiteSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)   % CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>Donor</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>592.5</td><td rowspan=1 colspan=1>48.3 (36.2-72.4)</td><td rowspan=1 colspan=1>8.1 (6.1-12.2)</td><td rowspan=1 colspan=1>26.7 (20.0-40.0)</td><td rowspan=1 colspan=1>4.5 (3.4-6.8)</td><td rowspan=1 colspan=1>8.8 (6.6-13.1)</td><td rowspan=1 colspan=1>1.5 (1.1-2.2)</td><td rowspan=1 colspan=1>54.4 (40.8-81.6)</td><td rowspan=1 colspan=1>9.2 (6.9-13.8)</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>599.2</td><td rowspan=1 colspan=1>54.0 (40.5-80.9)</td><td rowspan=1 colspan=1>9.0 (6.8-13.5)</td><td rowspan=1 colspan=1>8.5 (6.4-12.8)</td><td rowspan=1 colspan=1>1.4 (1.1-2.1)</td><td rowspan=1 colspan=1>15.0 (11.3-22.5)</td><td rowspan=1 colspan=1>2.5 (1.9-3.8)</td><td rowspan=1 colspan=1>52.4 (39.3-78.6)</td><td rowspan=1 colspan=1>8.7 (6.6-13.1)</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>187.3</td><td rowspan=1 colspan=1>13.0 (9.8-19.5)</td><td rowspan=1 colspan=1>6.9 (5.2-10.4)</td><td rowspan=1 colspan=1>6.5 (4.9-9.7)</td><td rowspan=1 colspan=1>3.5 (2.6-5.2)</td><td rowspan=1 colspan=1>12.2 (9.1-18.2)</td><td rowspan=1 colspan=1>6.5 (4.9-9.7)</td><td rowspan=1 colspan=1>21.0 (15.8-31.5)</td><td rowspan=1 colspan=1>11.2 (8.4-16.8)</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>868.9</td><td rowspan=1 colspan=1>61.2 (46.0-91.8)</td><td rowspan=1 colspan=1>7.0 (5.3-10.6)</td><td rowspan=1 colspan=1>23.0 (17.2-34.4)</td><td rowspan=1 colspan=1>2.6 (2.0-4.0)</td><td rowspan=1 colspan=1>47.7 (35.8-71.4)</td><td rowspan=1 colspan=1>5.5 (4.1-8.2)</td><td rowspan=1 colspan=1>89.6 (67.2-134.3)</td><td rowspan=1 colspan=1>10.3 (7.7-15.5)</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>527.1</td><td rowspan=1 colspan=1>28.0 (21.0-42.0)</td><td rowspan=1 colspan=1>5.3 (4.0-8.0)</td><td rowspan=1 colspan=1>34.9 (26.2-52.4)</td><td rowspan=1 colspan=1>6.6 (5.0-9.9)</td><td rowspan=1 colspan=1>30.1 (22.6-45.1)</td><td rowspan=1 colspan=1>5.7 (4.3-8.6)</td><td rowspan=1 colspan=1>51.0 (38.3-76.5)</td><td rowspan=1 colspan=1>9.7 (7.3-14.5)</td></tr></table>

ble 8 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD8 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD4</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-SiteSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)    % CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>Donor</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>782.1</td><td rowspan=1 colspan=1>26.7 (20.0-40.0)</td><td rowspan=1 colspan=1>3.4 (2.6-5.1)</td><td rowspan=1 colspan=1>4.3 (3.2-6.5)</td><td rowspan=1 colspan=1>0.6 (0.4-0.8)</td><td rowspan=1 colspan=1>17.4 (13.0-26.1)</td><td rowspan=1 colspan=1>2.2 (1.7-3.3)</td><td rowspan=1 colspan=1>48.8 (36.6-73.2)</td><td rowspan=1 colspan=1>6.2 (4.7-9.4)</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>828.2</td><td rowspan=1 colspan=1>46.0 (34.5-68.9)</td><td rowspan=1 colspan=1>5.6 (4.2-8.3)</td><td rowspan=1 colspan=1>24.7 (18.5-37.0)</td><td rowspan=1 colspan=1>3.0 (2.2-4.5)</td><td rowspan=1 colspan=1>12.9 (9.7-19.4)</td><td rowspan=1 colspan=1>1.6 (1.2-2.3)</td><td rowspan=1 colspan=1>51.6 (38.7-77.4)</td><td rowspan=1 colspan=1>6.2 (4.7-9.3)</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>165.9</td><td rowspan=1 colspan=1>5.0 (3.8-7.5)</td><td rowspan=1 colspan=1>3.0 (2.3-4.5)</td><td rowspan=1 colspan=1>0.6 (0.5-1.0)</td><td rowspan=1 colspan=1>0.4 (0.3-0.6)</td><td rowspan=1 colspan=1>7.6 (5.7-11.4)</td><td rowspan=1 colspan=1>4.6 (3.4-6.9)</td><td rowspan=1 colspan=1>16.3 (12.2-24.4)</td><td rowspan=1 colspan=1>9.8 (7.4-14.7)</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>488.2</td><td rowspan=1 colspan=1>23.8 (17.9-35.7)</td><td rowspan=1 colspan=1>4.9 (3.7-7.3)</td><td rowspan=1 colspan=1>10.9 (8.2-16.4)</td><td rowspan=1 colspan=1>2.2 (1.7-3.4)</td><td rowspan=1 colspan=1>19.5 (14.7-29.3)</td><td rowspan=1 colspan=1>4.0 (3.0-6.0)</td><td rowspan=1 colspan=1>42.7 (32.0-64.0)</td><td rowspan=1 colspan=1>8.7 (6.6-13.1)</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>646.1</td><td rowspan=1 colspan=1>13.7 (10.3-20.5)</td><td rowspan=1 colspan=1>2.1 (1.6-3.2)</td><td rowspan=1 colspan=1>36.4 (27.3-54.6)</td><td rowspan=1 colspan=1>5.6 (4.2-8.5)</td><td rowspan=1 colspan=1>28.0 (21.0-42.0)</td><td rowspan=1 colspan=1>4.3 (3.3-6.5)</td><td rowspan=1 colspan=1>48.5 (36.4-72.7)</td><td rowspan=1 colspan=1>7.5 (5.6-11.3)</td></tr></table>

ble 9 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD4 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD45</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-SiteSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)    % CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>Donor</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2221.6</td><td rowspan=1 colspan=1>124.3 (93.3-186.4)</td><td rowspan=1 colspan=1>5.6 (4.2-8.4)</td><td rowspan=1 colspan=1>27.1 (20.4-40.7)</td><td rowspan=1 colspan=1>1.2 (0.9-1.8)</td><td rowspan=1 colspan=1>29.1 (21.9-43.7)</td><td rowspan=1 colspan=1>1.3 (1.0-2.0)</td><td rowspan=1 colspan=1>146.2 (109.7-219.2)</td><td rowspan=1 colspan=1>6.6 (4.9-9.9)</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2122.5</td><td rowspan=1 colspan=1>167.2 (125.5-250.7)</td><td rowspan=1 colspan=1>7.9 (5.9-11.8)</td><td rowspan=1 colspan=1>35.0 (26.3-52.5)</td><td rowspan=1 colspan=1>1.6 (1.2-2.5)</td><td rowspan=1 colspan=1>47.4 (35.6-71.1)</td><td rowspan=1 colspan=1>2.2 (1.7-3.4)</td><td rowspan=1 colspan=1>162.6 (122.0-243.8)</td><td rowspan=1 colspan=1>7.7 (5.7-11.5)</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>613.3</td><td rowspan=1 colspan=1>22.1 (16.6-33.1)</td><td rowspan=1 colspan=1>3.6 (2.7-5.4)</td><td rowspan=1 colspan=1>19.0 (14.3-28.5)</td><td rowspan=1 colspan=1>3.1 (2.3-4.6)</td><td rowspan=1 colspan=1>38.8 (29.1-58.1)</td><td rowspan=1 colspan=1>6.3 (4.7-9.5)</td><td rowspan=1 colspan=1>53.1 (39.8-79.6)</td><td rowspan=1 colspan=1>8.7 (6.5-13.0)</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1806.2</td><td rowspan=1 colspan=1>111.6 (83.7-167.2)</td><td rowspan=1 colspan=1>6.2 (4.6-9.3)</td><td rowspan=1 colspan=1>60.1 (45.1-90.1)</td><td rowspan=1 colspan=1>3.3 (2.5-5.0)</td><td rowspan=1 colspan=1>102.8 (7.2-154.2)</td><td rowspan=1 colspan=1>5.7 (4.3-8.5)</td><td rowspan=1 colspan=1>154.2 (115.7-231.2)</td><td rowspan=1 colspan=1>8.5 (6.4-12.8)</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1743.8</td><td rowspan=1 colspan=1>80.2 (60.2-120.2)</td><td rowspan=1 colspan=1>4.6 (3.5-6.9)</td><td rowspan=1 colspan=1>77.4 (58.1-116.0)</td><td rowspan=1 colspan=1>4.4 (3.3-6.7)</td><td rowspan=1 colspan=1>100.6 (75.5-150.9)</td><td rowspan=1 colspan=1>5.8 (4.3-8.7)</td><td rowspan=1 colspan=1>131.6 (98.8-197.3)</td><td rowspan=1 colspan=1>7.5 (5.7-11.3)</td></tr></table>

10 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD45 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD16/CD56</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-SiteSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)   % CV (95% CI)</td></tr><tr><td rowspan=1 colspan=3>Donor    N   Mean</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>358.1</td><td rowspan=1 colspan=1>22.9 (17.2-34.3)</td><td rowspan=1 colspan=1>6.4 (4.8-9.6)</td><td rowspan=1 colspan=1>11.2 (8.4-16.8)</td><td rowspan=1 colspan=1>3.1 (2.4-4.7)</td><td rowspan=1 colspan=1>21.9 (16.5-32.9)</td><td rowspan=1 colspan=1>6.1 (4.6-9.2)</td><td rowspan=1 colspan=1>33.5 (25.1-50.2)</td><td rowspan=1 colspan=1>9.4 (7.0-14.0)</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>484.1</td><td rowspan=1 colspan=1>36.3 (27.0-55.2)</td><td rowspan=1 colspan=1>7.5 (5.6-11.4)</td><td rowspan=1 colspan=1>37.4 (27.9-57.0)</td><td rowspan=1 colspan=1>7.7 (5.7-11.7)</td><td rowspan=1 colspan=1>28.1 (21.0-42.8)</td><td rowspan=1 colspan=1>5.8 (4.3-8.8)</td><td rowspan=1 colspan=1>57.6 (42.9-87.7)</td><td rowspan=1 colspan=1>11.9 (8.8-18.1)</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>153.5</td><td rowspan=1 colspan=1>5.2 (3.9-7.8)</td><td rowspan=1 colspan=1>3.4 (2.6-5.1)</td><td rowspan=1 colspan=1>7.6 (5.7-11.5)</td><td rowspan=1 colspan=1>5.0 (3.7-7.5)</td><td rowspan=1 colspan=1>10.0 (7.5-15.0)</td><td rowspan=1 colspan=1>6.5 (4.9-9.8)</td><td rowspan=1 colspan=1>14.7 (11.0-22.0)</td><td rowspan=1 colspan=1>9.6 (7.2-14.4)</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>275.1</td><td rowspan=1 colspan=1>12.3 (9.2-18.4)</td><td rowspan=1 colspan=1>4.5 (3.3-6.7)</td><td rowspan=1 colspan=1>14.2 (10.7-21.3)</td><td rowspan=1 colspan=1>5.2 (3.9-7.7)</td><td rowspan=1 colspan=1>19.1 (14.3-28.6)</td><td rowspan=1 colspan=1>6.9 (5.2-10.4)</td><td rowspan=1 colspan=1>29.1 (21.8-43.6)</td><td rowspan=1 colspan=1>10.6 (7.9-15.9)</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>402.0</td><td rowspan=1 colspan=1>26.4 (19.8-39.6)</td><td rowspan=1 colspan=1>6.6 (4.9-9.9)</td><td rowspan=1 colspan=1>16.1 (12.1-24.1)</td><td rowspan=1 colspan=1>4.0 (3.0-6.0)</td><td rowspan=1 colspan=1>20.3 (15.2-30.4)</td><td rowspan=1 colspan=1>5.0 (3.8-7.6)</td><td rowspan=1 colspan=1>34.7 (26.0-52.0)</td><td rowspan=1 colspan=1>8.6 (6.5-12.9)</td></tr></table>

demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD16/56 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

<table><tr><td rowspan=1 colspan=1>CD19</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=2>Between-SiteSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>Between-TubeSD (95% CI)    % CV (95% CI)</td><td rowspan=2 colspan=2>Between-ReplicateSD (95% CI)   % CV (95% CI)</td><td rowspan=2 colspan=2>TotalSD (95% CI)   % CV (95% CI)</td></tr><tr><td rowspan=1 colspan=1>Donor</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>351.7</td><td rowspan=1 colspan=1>25.5 (19.1-38.2)</td><td rowspan=1 colspan=1>7.2 (5.4-10.8)</td><td rowspan=1 colspan=1>1.9 (1.4-2.8)</td><td rowspan=1 colspan=1>0.5 (0.4-0.8)</td><td rowspan=1 colspan=1>5.2 (3.9-7.8)</td><td rowspan=1 colspan=1>1.5 (1.1-2.2)</td><td rowspan=1 colspan=1>31.2 (23.4-46.8)</td><td rowspan=1 colspan=1>8.9 (6.7-13.3)</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>141.9</td><td rowspan=1 colspan=1>7.5 (5.6-11.5)</td><td rowspan=1 colspan=1>5.4(4.0-8.1)</td><td rowspan=1 colspan=1>6.2 (4.6-9.4)</td><td rowspan=1 colspan=1>4.4 (3.3-6.6)</td><td rowspan=1 colspan=1>8.8 (6.5-13.4)</td><td rowspan=1 colspan=1>6.2 (4.6-9.5)</td><td rowspan=1 colspan=1>14.2 (10.6-21.6)</td><td rowspan=1 colspan=1>10.1 (7.5-15.3)</td></tr><tr><td rowspan=1 colspan=1>C</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>53.7</td><td rowspan=1 colspan=1>0.5 (0.3-0.7)</td><td rowspan=1 colspan=1>0.8 (0.6-1.3)</td><td rowspan=1 colspan=1>0.9 (0.7-1.3)</td><td rowspan=1 colspan=1>1.7 (1.3-2.5)</td><td rowspan=1 colspan=1>3.2 (2.4-4.8)</td><td rowspan=1 colspan=1>6.0 (4.5-9.0)</td><td rowspan=1 colspan=1>4.0 (3.0-6.0)</td><td rowspan=1 colspan=1>7.4 (5.6-11.2)</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90.4</td><td rowspan=1 colspan=1>6.2 (4.7-9.3)</td><td rowspan=1 colspan=1>6.9 (5.2-10.3)</td><td rowspan=1 colspan=1>5.9 (4.4-8.8)</td><td rowspan=1 colspan=1>6.5 (4.9-9.8)</td><td rowspan=1 colspan=1>5.9 (4.4-8.9)</td><td rowspan=1 colspan=1>6.6 (4.9-9.8)</td><td rowspan=1 colspan=1>10.8 (8.1-16.2)</td><td rowspan=1 colspan=1>11.9 (9.0-17.9)</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>97.7</td><td rowspan=1 colspan=1>6.2 (4.6-9.2)</td><td rowspan=1 colspan=1>6.3 (4.7-9.4)</td><td rowspan=1 colspan=1>0.1 (0.1-0.2)</td><td rowspan=1 colspan=1>0.1 (0.1-0.2)</td><td rowspan=1 colspan=1>8.9 (6.7-13.3)</td><td rowspan=1 colspan=1>9.1 (6.8-13.6)</td><td rowspan=1 colspan=1>10.9 (8.2-16.3)</td><td rowspan=1 colspan=1>11.2 (8.4-16.7)</td></tr></table>

12 demonstrates that the $3 \mathrm { m L }$ TVT lots were sufficiently precise for the CD19 biomarker (individual and total $\% C V s$ were less than $10 \%$ and $1 5 \%$ , respectively).

Results showed that after evaluating the TVT investigational product for Between-Site, BetweenTube, and Between-Replicate variability across all biomarkers, it was sufficiently precise.

Equivalence- Method Comparisons against Becton Dickinson EDTA (BD EDTA Day 0, control) and predicate

A clinical study validated the stability of lymphocyte subsets (CD3, CD4, CD8, CD16/56, CD19 and CD45) in TVT tubes. Samples were collected $3 0 \mathrm { H I V }$ positive donors and 12 normal donors into BD EDTA tubes (reference condition), TVT tubes and BCT tubes. All tube types underwent testing for all markers on Day 0 (within 6 hours of collection), and TVT and BCT tubes were assayed on Days 11 and 15 post collection. All samples at all time points were analyzed by flow cytometry using a single-platform method. Passing –Bablok regression was performed to assess the relationship between the measurement for each marker from each time point and the control BD EDTA tube.

# Summary for HIV positive subjects as compared to control $\scriptstyle ( \mathbf { n } = 3 \mathbf { 0 } )$ (Absolute counts) This analysis is BCT and TVT vs BD for each marker.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=5>Passing-Bablok Regression</td></tr><tr><td rowspan=1 colspan=1>Marker</td><td rowspan=1 colspan=1>Tube</td><td rowspan=1 colspan=1>TimeInterval</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=2>95% CI for Slope</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=6 colspan=1>CD3</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-3.4</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=2>0.9478to 1.039</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-18.1</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=2>0.9773 to 1.142</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>28.9</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>0.9071</td><td rowspan=1 colspan=1>to 1.074</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-31.7</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>0.9493</td><td rowspan=1 colspan=1>0.9493 to 1.207</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>52.2</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>0.8882</td><td rowspan=1 colspan=1>to 1.034</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-13.8</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=1>0.9425 to 1.154</td><td rowspan=1 colspan=1>0.9425 to 1.154</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=6 colspan=1>CD4</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>0.9325</td><td rowspan=1 colspan=1>to 1.013</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>0.9636</td><td rowspan=1 colspan=1>0.9636 to 1.089</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>1.9</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>0.9076 to 1.024</td><td rowspan=1 colspan=1>0.9076 to 1.024</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>11.5</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>0.9159</td><td rowspan=1 colspan=1>0.9159 to 1.027</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>to 1.027</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=1>0.8558 to 1.067</td><td rowspan=1 colspan=1>0.8558 to 1.067</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=6 colspan=1>CD8</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-12.2</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>0.9467</td><td rowspan=1 colspan=1>to 1.074</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-60.5</td><td rowspan=1 colspan=1>1.12</td><td rowspan=1 colspan=1>1.0481</td><td rowspan=1 colspan=1>to 1.196</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=1>0.9398</td><td rowspan=1 colspan=1>to 1.142</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-26.3</td><td rowspan=1 colspan=1>1.08</td><td rowspan=1 colspan=1>0.9823</td><td rowspan=1 colspan=1>0.9823 to 1.191</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>47.9</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>0.8793</td><td rowspan=1 colspan=1>0.8793 to 1.055</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>1.03</td><td rowspan=1 colspan=1>0.8790 to 1.179</td><td rowspan=1 colspan=1>0.8790 to 1.179</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=6 colspan=1>CD16/56</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>1.08</td><td rowspan=1 colspan=1>0.9451</td><td rowspan=1 colspan=1>to 1.189</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>0.9278 to 1.172</td><td rowspan=1 colspan=1>0.9278 to 1.172</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>1.10</td><td rowspan=1 colspan=1>0.9681</td><td rowspan=1 colspan=1>to 1.205</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>10.3</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>0.7929</td><td rowspan=1 colspan=1>0.7929 to 1.118</td><td rowspan=1 colspan=1>0.95</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>20.3</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>0.8554</td><td rowspan=1 colspan=1>0.8554 to 1.090</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>15.7</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>0.8079</td><td rowspan=1 colspan=1>0.8079 to 1.139</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=6 colspan=1>CD19</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>0.9735 to 1.072</td><td rowspan=1 colspan=1>0.9735 to 1.072</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>0.9361</td><td rowspan=1 colspan=1>to 1.078</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-5.8</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>0.9779</td><td rowspan=1 colspan=1>0.9779 to 1.109</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-4.8</td><td rowspan=1 colspan=1>1.07</td><td rowspan=1 colspan=1>0.9437 to 1.149</td><td rowspan=1 colspan=1>0.9437 to 1.149</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-2.2</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>0.8950</td><td rowspan=1 colspan=1> to 1.031</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-5.8</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>0.9489 to 1.123</td><td rowspan=1 colspan=1>0.9489 to 1.123</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=6 colspan=1>CD45</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>13.6</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>0.9501</td><td rowspan=1 colspan=1>to 1.049</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-10.5</td><td rowspan=1 colspan=1>1.07</td><td rowspan=1 colspan=1>0.9978</td><td rowspan=1 colspan=1>0.9978 to 1.153</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>19.3</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>0.9435</td><td rowspan=1 colspan=1>to 1.101</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-32.5</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>0.9718 to 1.167</td><td rowspan=1 colspan=1>0.9718 to 1.167</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>9.4</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>0.9384</td><td rowspan=1 colspan=1>to 1.076</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=2>0.9232 to 1.137</td><td rowspan=1 colspan=1>0.97</td></tr></table>

# Dynamic range summary for HIV positive subjects $\scriptstyle ( \mathbf { n } = 3 \mathbf { 0 } )$ ) (Absolute counts):

<table><tr><td rowspan=1 colspan=1>Marker</td><td rowspan=1 colspan=1>Tube</td><td rowspan=1 colspan=1>TimeInterval</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Min</td><td rowspan=1 colspan=1>Max</td></tr><tr><td rowspan=1 colspan=1>CD3</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>1415.9</td><td rowspan=1 colspan=1>226.3</td><td rowspan=1 colspan=1>3741.1</td></tr><tr><td rowspan=1 colspan=1>CD4</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>520.3</td><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>1142.4</td></tr><tr><td rowspan=1 colspan=1>CD8</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>878.0</td><td rowspan=1 colspan=1>217.4</td><td rowspan=1 colspan=1>3017.8</td></tr><tr><td rowspan=1 colspan=1>CD16/56</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>227.6</td><td rowspan=1 colspan=1>33.2</td><td rowspan=1 colspan=1>656.6</td></tr><tr><td rowspan=1 colspan=1>CD19</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>199.7</td><td rowspan=1 colspan=1>0.2</td><td rowspan=1 colspan=1>520.7</td></tr><tr><td rowspan=1 colspan=1>CD45</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>1853.7</td><td rowspan=1 colspan=1>298.6</td><td rowspan=1 colspan=1>4556.0</td></tr></table>

# Summary for Healthy Subjects $( \mathbf { n } { = } 1 2 )$ (Absolute counts)- This analysis is BCT and TVT vs BD for each marker.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=5>Passing-Bablok Regression</td></tr><tr><td rowspan=1 colspan=1>Marker</td><td rowspan=1 colspan=1>Tube</td><td rowspan=1 colspan=1>TimeInterval</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=2>95% CI for Slope</td><td rowspan=1 colspan=1>R</td></tr><tr><td rowspan=6 colspan=1>CD3</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>75.9</td><td rowspan=1 colspan=1>0.92</td><td rowspan=1 colspan=2>0.7386 to 1.048</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-14.3</td><td rowspan=1 colspan=1>1.03</td><td rowspan=1 colspan=2>0.9415 to 1.226</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>189.6</td><td rowspan=1 colspan=1>0.83</td><td rowspan=1 colspan=2>0.6452to 0.965</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-178.6</td><td rowspan=1 colspan=1>1.10</td><td rowspan=1 colspan=2>1.0392 to 1.445</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>38.9</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=2>0.7709to 1.107</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-69.5</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=2>0.9630 to 1.221</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=6 colspan=1>CD4</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>33.4</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=2>0.8592to 1.131</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>19.0</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=2>0.8749 to 1.209</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>123.9</td><td rowspan=1 colspan=1>0.82</td><td rowspan=1 colspan=2>0.7653to 0.925</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-76.7</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=2>0.9407 to 1.212</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>66.0</td><td rowspan=1 colspan=1>0.88</td><td rowspan=1 colspan=2>0.8084to 1.180</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-28.4</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=2>0.9592 to 1.303</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=6 colspan=1>CD8</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>66.0</td><td rowspan=1 colspan=1>0.86</td><td rowspan=1 colspan=1>0.6987</td><td rowspan=1 colspan=1>to 0.976</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>20.5</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=1>0.5831</td><td rowspan=1 colspan=1>0.5831 to 1.176</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>35.3</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>0.7903</td><td rowspan=1 colspan=1>to 1.021</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>32.8</td><td rowspan=1 colspan=1>0.90</td><td rowspan=1 colspan=2>0.4914 to 1.015</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>37.2</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=2>0.8106 to 1.090</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>48.1</td><td rowspan=1 colspan=1>0.90</td><td rowspan=1 colspan=2>0.4299 to 1.032</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=6 colspan=1>CD16/56</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>23.4</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=2>0.5042to 1.117</td><td rowspan=1 colspan=1>0.93</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-23.0</td><td rowspan=1 colspan=1>1.10</td><td rowspan=1 colspan=2>0.6485 to 1.403</td><td rowspan=1 colspan=1>0.92</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-24.4</td><td rowspan=1 colspan=1>1.23</td><td rowspan=1 colspan=2>0.6715to 1.528</td><td rowspan=1 colspan=1>0.90</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>6.0</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=2>0.6636 to 1.311</td><td rowspan=1 colspan=1>0.89</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-30.2</td><td rowspan=1 colspan=1>1.19</td><td rowspan=1 colspan=1>0.8838</td><td rowspan=1 colspan=1> to 1.363</td><td rowspan=1 colspan=1>0.91</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-11.7</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=2>0.7030 to 1.377</td><td rowspan=1 colspan=1>0.90</td></tr><tr><td rowspan=6 colspan=1>CD19</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-4.1</td><td rowspan=1 colspan=1>1.06</td><td rowspan=1 colspan=2>0.8942to 1.233</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>14.4</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=2>0.5285 to 1.238</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-1.6</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>0.8060</td><td rowspan=1 colspan=1>to 1.451</td><td rowspan=1 colspan=1>0.95</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=2>0.7014 to 1.248</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=1>0.7719</td><td rowspan=1 colspan=1>to 1.258</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-5.0</td><td rowspan=1 colspan=1>1.08</td><td rowspan=1 colspan=2>0.8658 to 1.369</td><td rowspan=1 colspan=1>0.99</td></tr><tr><td rowspan=6 colspan=1>CD45</td><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>131.5</td><td rowspan=1 colspan=1>0.92</td><td rowspan=1 colspan=1>0.5996</td><td rowspan=1 colspan=1>to 1.018</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>-78.1</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=2>0.8239 to 1.354</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>295.4</td><td rowspan=1 colspan=1>0.82</td><td rowspan=1 colspan=1>0.5367</td><td rowspan=1 colspan=1>to 1.248</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>11 day</td><td rowspan=1 colspan=1>-322.8</td><td rowspan=1 colspan=1>1.14</td><td rowspan=1 colspan=1>0.9225</td><td rowspan=1 colspan=1>0.9225 to 1.427</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>BCT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>137.9</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>0.7036</td><td rowspan=1 colspan=1> to 1.095</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>TVT</td><td rowspan=1 colspan=1>15 day</td><td rowspan=1 colspan=1>-42.4</td><td rowspan=1 colspan=1>1.04</td><td rowspan=1 colspan=2>0.7490 to 1.293</td><td rowspan=1 colspan=1>0.98</td></tr></table>

Dynamic range summary for Healthy Subjects $\scriptstyle ( \mathbf { n } = 1 2$ ) (Absolute counts):   

<table><tr><td rowspan=1 colspan=1>Marker</td><td rowspan=1 colspan=1>Tube</td><td rowspan=1 colspan=1>TimeInterval Mean</td><td rowspan=1 colspan=1>Interval Mean</td><td rowspan=1 colspan=1>Min</td><td rowspan=1 colspan=1>Max</td></tr><tr><td rowspan=1 colspan=1>CD3</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>1493.1</td><td rowspan=1 colspan=1>772.2</td><td rowspan=1 colspan=1>2819.4</td></tr><tr><td rowspan=1 colspan=1>CD4</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>953.6</td><td rowspan=1 colspan=1>493.8</td><td rowspan=1 colspan=1>2068.0</td></tr><tr><td rowspan=1 colspan=1>CD8</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>522.1</td><td rowspan=1 colspan=1>220.5</td><td rowspan=1 colspan=1>990.6</td></tr><tr><td rowspan=1 colspan=1>CD16/56</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>279.3</td><td rowspan=1 colspan=1>113.7</td><td rowspan=1 colspan=1>497.3</td></tr><tr><td rowspan=1 colspan=1>CD19</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>211.3</td><td rowspan=1 colspan=1>122.0</td><td rowspan=1 colspan=1>428.0</td></tr><tr><td rowspan=1 colspan=1>CD45</td><td rowspan=1 colspan=1>BD</td><td rowspan=1 colspan=1>6 hour</td><td rowspan=1 colspan=1>2009.0</td><td rowspan=1 colspan=1>1453.2</td><td rowspan=1 colspan=1>3452.4</td></tr></table>

# Interference

One site recruited five healthy subjects (individuals with no known disease process and ${ \geq } 2 1$ years of age) and five HIV positive subjects. From each subject, two peripheral blood samples were collected in 4mL K3 EDTA Vacutainers. Immediately after collection, the $2 \mathrm { x } \ 4 \mathrm { m L }$ blood samples were split into seven $1 \mathrm { m L }$ aliquots.

 Aliquot 1) was treated as a control (no interfering substance). The other aliquots were manipulated as follows:   
 Aliquot 2) had $2 \mu \mathrm { g } / \mathrm { m l }$ $( 0 . 2 \mathrm { m g / d L } )$ bilirubin added to it.   
 Aliquot 3) had $2 0 0 \mu \mathrm { g / m l }$ $( 2 0 \mathrm { m g / d L } )$ bilirubin added to it.   
 Aliquot 4) had $0 . 0 2 5 ~ \mathrm { g / m l }$ $( 2 . 5 \ \mathrm { g / d L } )$ hemoglobin added to it.   
 Aliquot 5) had $0 . 0 3 5 \mathrm { g / m l }$ $( 3 . 5 \ \mathrm { g / d L } )$ hemoglobin added to it. Aliquot 6) had $1 . 5 \mathrm { m g / m l }$ ( $1 5 0 \mathrm { m g / d L } )$ triglycerides added to it.   
 Aliquot 7) had $5 \mathrm { m g / m l }$ $( 5 0 0 \mathrm { m g / d L } )$ triglycerides added to it.

The aliquots were then stabilized using the appropriate amount of TransFix following the manufacturer’s instructions, i.e., $0 . 2 ~ \mathrm { m L }$ TransFix administered to the 1mL aliquot, and were then stored at $2 { - } 8 ^ { \circ } \mathrm { C }$ between test days. Aliquots were analyzed for a full lymphocyte count on Days 0, 11, and 15. The data indicated that there were no significant effects from the potential interferents listed above, as the results from testing Aliquots 2-7 were similar to results from the testing of Aliquot 1 (control).

# 807.92 (b)(3): Conclusions from Nonclinical and Clinical Testing

The TVT tubes were found to be safe and effective for the intended use.